| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |